| NM_004956 |
ETV1 |
ets variant 1 |
| NM_002153 |
HSD17B2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
| NM_032211 |
LOXL4 |
lysyl oxidase-like 4 |
| NM_001786 |
CDK1 |
cyclin-dependent kinase 1 |
| NM_000210 |
ITGA6 |
integrin, alpha 6 |
| NM_001946 |
DUSP6 |
dual specificity phosphatase 6 |
| NM_005415 |
SLC20A1 |
solute carrier family 20 (phosphate transporter), member 20 |
| NM_002692 |
POLE2 |
polymerase (DNA directed), epsilon 2 (p59 subunit) |
| NM_001237 |
CCNA2 |
cyclin A2 |
| NM_005915 |
MCM6 |
minichromosome maintenance complex component 6 |
| NM_002276 |
KRT19 |
keratin 19 |
| NM_002915 |
RFC3 |
replication factor C (activator 1) 3, 38kDa |
| NM_021013 |
KRT34 |
keratin 34 |
| NM_203394 |
E2F7 |
E2F transcription factor 7 |
| NR_027676 |
BRCA1 |
breast cancer 1, early onset |
| NM_001128620 |
PAK1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
| NM_018063 |
HELLS |
helicase, lymphoid-specific |
| NM_139314 |
ANGPTL4 |
angiopoietin-like 4 |
| NM_000885 |
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
| NM_001141945 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
| NM_053056 |
CCND1 |
cyclin D1 |
| NM_005523 |
HOXA11 |
homeobox A11 |
| NM_002204 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
| NM_003505 |
FZD1 |
frizzled homolog 1 (Drosophila) |
| NM_002689 |
POLA2 |
polymerase (DNA directed), alpha 2 (70kD subunit) |
| NM_002213 |
ITGB5 |
integrin, beta 5 |
| NM_001153 |
ANXA4 |
annexin A4 |
| NM_000362 |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
| NM_020396 |
BCL2L10 |
BCL2-like 10 (apoptosis facilitator) |
| NM_001127217 |
SMAD9 |
SMAD family member 9 |
| NM_006547 |
IGF2BP3 |
insulin-like growth factor 2 mRNA binding protein 3 |
| NM_001735 |
C5 |
complement component 5 |
| NM_003243 |
TGFBR3 |
transforming growth factor, beta receptor III |
| NM_012098 |
ANGPTL2 |
angiopoietin-like 2 |
| NM_000043 |
FAS |
Fas (TNF receptor superfamily, member 6) |
| NM_002291 |
LAMB1 |
laminin, beta 1 |
| NM_148957 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
| NM_025208 |
PDGFD |
platelet derived growth factor D |
| NM_002425 |
MMP10 |
matrix metallopeptidase 10 (stromelysin 2) |
| NM_000640 |
IL13RA2 |
interleukin 13 receptor, alpha 2 |
| NM_057749 |
CCNE2 |
cyclin E2 |
| NM_002658 |
PLAU |
plasminogen activator, urokinase |
| NM_014791 |
MELK |
maternal embryonic leucine zipper kinase |
| NM_002203 |
ITGA2 |
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
| NM_001178010 |
CDC45 |
cell division cycle 45 homolog (S. cerevisiae) |
| NM_006461 |
SPAG5 |
sperm associated antigen 5 |
| NM_000059 |
BRCA2 |
breast cancer 2, early onset |
| NM_024680 |
E2F8 |
E2F transcription factor 8 |
| NM_002422 |
MMP3 |
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
| NM_006739 |
MCM5 |
minichromosome maintenance complex component 5 |
| NM_002388 |
MCM3 |
minichromosome maintenance complex component 3 |
| NM_004153 |
ORC1 |
origin recognition complex, subunit 1 |
| NM_002592 |
PCNA |
proliferating cell nuclear antigen |
| NM_005225 |
E2F1 |
E2F transcription factor 1 |
| NM_000575 |
IL1A |
interleukin 1, alpha |
| NM_005438 |
FOSL1 |
FOS-like antigen 1 |
